Net Product Revenue: $2.1 million from KOMZIFTI sales in Q4 2025. Collaboration Revenue: $15.2 million from Kyowa Kirin partnership in Q4 2025, compared to $53.9 million in Q4 2024. Research and ...

The game’s success could open the doors for future developments, including map expansions and additional characters, says Nur Naquyah. — ART CHEN/The Star One of the pioneering forces behind ...

Kura Oncology (KURA) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to a loss of $0.22 per share a year ago. These figures are ...

Kura Oncology (NASDAQ:KURA) executives used the company’s fourth-quarter and fiscal 2025 earnings call to highlight what CEO Troy Wilson called a “defining year,” driven by the FDA approval of ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Kura Oncology Inc. (KURA) on Thursday reported a loss of $81 million in its fourth quarter. The San Diego-based company said it had a loss of 92 cents per share. The ...

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2025 Earnings Call Transcript March 5, 2026 Kura Oncology, Inc. misses on earnings expectations. Reported EPS is $-0.92 EPS, expectations were $-0.72. Abigail: ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Kura Revolving Sushi Bar offers more than 100 dishes that circulate on a double conveyor belt system, covered with a ventilated lid. Courtesy of Kura Sushi Kura Sushi, where diners can grab food as it ...

- Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, supporting ongoing development plans targeting up to 50% of AML patients - SAN DIEGO, March 05, 2026 ...